Dynlt3 — Dynein Light Chain Tctex Type 3 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Dynlt3 — Dynein Light Chain Tctex Type 3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Dynein Light Chain Tctex-Type 3 | |
|---|---|
| Gene Symbol | DYNLT3 |
| Full Name | Dynein Light Chain Tctex-Type 3 |
| Chromosome | 11p15 |
| NCBI Gene ID | 6995 |
| OMIM | 611414 |
| Ensembl ID | ENSG00000137336 |
| UniProt ID | Q9NPF4 |
| Associated Diseases | Huntington's Disease, Spinal Muscular Atrophy |
DYNLT3 encodes a dynein light chain protein that is part of the cytoplasmic dynein motor complex. Like DYNLT1, DYNLT3 can form homodimers and may have distinct cargo binding specificities compared to other dynein light chains. DYNLT3 is expressed in neurons and has been implicated in the transport of signaling molecules and organelles. While its specific neuronal functions are less characterized than DYNLT1, DYNLT3 is thought to play complementary roles in dynein-mediated transport. Studies suggest alterations in dynein function may contribute to the pathogenesis of spinal muscular atrophy and Huntington's disease.
DYNLT3 is expressed in:
Expressed in tissues with high transport requirements.
| Disease | Role | Mechanism |
|---|---|---|
| Alzheimer's Disease | Risk/Progression | Various mechanisms depending on gene function |
| Parkinson's Disease | Risk/Progression | Various mechanisms depending on gene function |
| Amyotrophic Lateral Sclerosis | Risk/Progression | Various mechanisms depending on gene function |
Targeting DYNLT3 has therapeutic potential in neurodegenerative diseases through:
Dynlt3 — Dynein Light Chain Tctex Type 3 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Dynlt3 — Dynein Light Chain Tctex Type 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.